Variant report

Variant	nsv575927
Chromosome Location	chr17:66787428-66817866
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr17:66789748-66791053	HepG2	liver:	n/a	n/a
2	ARID3A	chr17:66816464-66818880	HepG2	liver:	n/a	n/a
3	ARID3A	chr17:66791347-66791352	HepG2	liver:	n/a	n/a
4	ATF3	chr17:66790103-66790344	HepG2	liver:	n/a	n/a
5	BHLHE40	chr17:66816953-66817591	HepG2	liver:	n/a	n/a
6	BHLHE40	chr17:66789850-66790403	HepG2	liver:	n/a	n/a
7	CBX3	chr17:66816994-66818931	HCT-116	colon:	n/a	n/a
8	CEBPB	chr17:66817112-66817406	HepG2	liver:	n/a	n/a
9	CEBPB	chr17:66788303-66788547	ECC-1	luminal epithelium:	n/a	chr17:66788378-66788387 chr17:66788378-66788387 chr17:66788376-66788387 chr17:66788378-66788387 chr17:66788476-66788489
10	CEBPB	chr17:66816375-66818956	HCT-116	colon:	n/a	n/a
11	CEBPB	chr17:66788018-66788728	A549	lung:	n/a	chr17:66788378-66788387 chr17:66788378-66788387 chr17:66788376-66788387 chr17:66788378-66788387 chr17:66788476-66788489
12	CEBPB	chr17:66816735-66817638	HepG2	liver:	n/a	n/a
13	CEBPB	chr17:66788193-66788749	Hela-S3	cervix:	n/a	chr17:66788378-66788387 chr17:66788378-66788387 chr17:66788376-66788387 chr17:66788378-66788387 chr17:66788476-66788489
14	CEBPB	chr17:66816885-66817461	IMR90	lung:	n/a	n/a
15	CEBPB	chr17:66816860-66817425	K562	blood:	n/a	n/a
16	CEBPB	chr17:66788246-66788538	MCF-7	breast:	n/a	chr17:66788378-66788387 chr17:66788378-66788387 chr17:66788376-66788387 chr17:66788378-66788387 chr17:66788476-66788489
17	CEBPB	chr17:66787945-66788604	A549	lung:	n/a	chr17:66788378-66788387 chr17:66788378-66788387 chr17:66788376-66788387 chr17:66788378-66788387 chr17:66788476-66788489
18	CEBPB	chr17:66787897-66788577	HepG2	liver:	n/a	chr17:66788378-66788387 chr17:66788378-66788387 chr17:66788376-66788387 chr17:66788378-66788387 chr17:66788476-66788489
19	CEBPB	chr17:66816735-66817620	HepG2	liver:	n/a	n/a
20	CEBPB	chr17:66816814-66817541	HepG2	liver:	n/a	n/a
21	CEBPB	chr17:66787931-66788618	IMR90	lung:	n/a	chr17:66788378-66788387 chr17:66788378-66788387 chr17:66788376-66788387 chr17:66788378-66788387 chr17:66788476-66788489
22	CEBPB	chr17:66816981-66817464	A549	lung:	n/a	n/a
23	CEBPB	chr17:66790037-66790506	IMR90	lung:	n/a	chr17:66790056-66790068 chr17:66790324-66790335
24	CEBPB	chr17:66790042-66790499	Hela-S3	cervix:	n/a	chr17:66790056-66790068 chr17:66790324-66790335
25	CEBPB	chr17:66817138-66817414	H1-hESC	embryonic stem cell:	n/a	n/a
26	CEBPB	chr17:66790062-66790560	A549	lung:	n/a	chr17:66790324-66790335
27	CEBPB	chr17:66790050-66790539	HepG2	liver:	n/a	chr17:66790056-66790068 chr17:66790324-66790335
28	CEBPB	chr17:66816850-66817093	HepG2	liver:	n/a	n/a
29	CEBPB	chr17:66817112-66817460	Hela-S3	cervix:	n/a	n/a
30	CEBPB	chr17:66817025-66817682	HCT-116	colon:	n/a	n/a
31	CEBPB	chr17:66788201-66788582	A549	lung:	n/a	chr17:66788378-66788387 chr17:66788378-66788387 chr17:66788376-66788387 chr17:66788378-66788387 chr17:66788476-66788489
32	CEBPB	chr17:66789958-66790525	HepG2	liver:	n/a	chr17:66790056-66790068 chr17:66790324-66790335
33	CEBPB	chr17:66817071-66817490	A549	lung:	n/a	n/a
34	CEBPB	chr17:66817056-66817474	MCF-7	breast:	n/a	n/a
35	CEBPB	chr17:66817792-66818665	HCT-116	colon:	n/a	n/a
36	CEBPB	chr17:66787984-66788573	K562	blood:	n/a	chr17:66788378-66788387 chr17:66788378-66788387 chr17:66788376-66788387 chr17:66788378-66788387 chr17:66788476-66788489
37	CEBPB	chr17:66790050-66790424	A549	lung:	n/a	chr17:66790056-66790068 chr17:66790324-66790335
38	CEBPB	chr17:66789947-66790435	HepG2	liver:	n/a	chr17:66790056-66790068 chr17:66790324-66790335
39	CEBPB	chr17:66790085-66790491	A549	lung:	n/a	chr17:66790324-66790335
40	CEBPB	chr17:66789884-66790529	HepG2	liver:	n/a	chr17:66790056-66790068 chr17:66790324-66790335
41	CEBPB	chr17:66788146-66788575	H1-hESC	embryonic stem cell:	n/a	chr17:66788378-66788387 chr17:66788378-66788387 chr17:66788376-66788387 chr17:66788378-66788387 chr17:66788476-66788489
42	CEBPD	chr17:66790042-66790414	HepG2	liver:	n/a	n/a
43	CEBPD	chr17:66816820-66817514	HepG2	liver:	n/a	n/a
44	CEBPD	chr17:66816950-66817439	HepG2	liver:	n/a	n/a
45	CEBPD	chr17:66790041-66790446	HepG2	liver:	n/a	n/a
46	CHD2	chr17:66789904-66790383	HepG2	liver:	n/a	n/a
47	CHD2	chr17:66789975-66790365	Hela-S3	cervix:	n/a	n/a
48	CREB1	chr17:66789736-66790439	HepG2	liver:	n/a	n/a
49	CTCF	chr17:66813640-66813790	AG10803	skin:	n/a	n/a
50	CTCF	chr17:66790720-66790870	NHDF-neo	bronchial:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr17:66809994..66812325-chr17:66813453..66815058,2	MCF-7	breast:
2	chr17:66790371..66791470-chr17:66967983..66969294,6	MCF-7	breast:
3	chr17:66790796..66791327-chr8:90031920..90032588,2	MCF-7	breast:
4	chr17:66790411..66791366-chr17:67054059..67054582,2	K562	blood:
5	chr17:66808054..66811042-chr17:66815866..66818225,2	MCF-7	breast:
6	chr17:66678045..66679683-chr17:66805508..66807559,2	K562	blood:
7	chr17:66807443..66809225-chr17:66811395..66812998,2	K562	blood:
8	chr17:66807443..66809225-chr17:66811395..66812998,2	K562	blood:
9	chr17:66809994..66812325-chr17:66813453..66815058,2	MCF-7	breast:
10	chr17:66790395..66791436-chr17:67231389..67232511,9	MCF-7	breast:
11	chr17:66802632..66805530-chr17:66835836..66838172,2	MCF-7	breast:
12	chr17:66790300..66791288-chr17:66907471..66908085,3	MCF-7	breast:
13	chr17:66808533..66810777-chr17:66816260..66818804,2	K562	blood:
14	chr17:66789980..66791367-chr17:66902438..66903724,8	MCF-7	breast:
15	chr17:66808533..66810777-chr17:66816260..66818804,2	K562	blood:
16	chr17:66808054..66811042-chr17:66815866..66818225,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PRKAR1A-5	chr17:66810317-66813242	NONHSAT055555
2	lnc-ABCA8-1	chr17:66805273-66805535	XLOC_012559
3	lnc-ABCA8-2	chr17:66796269-66796516	XLOC_012558
4	lnc-PRKAR1A-5	chr17:66810092-66813017	FPKM1_group_13223_transcript_1
5	lnc-ABCA8-2	chr17:66789690-66789845	ENSG00000267250.1
6	lnc-PRKAR1A-5	chr17:66810067-66810228	NONHSAT055555
7	lnc-ABCA8-2	chr17:66794693-66794891	XLOC_012558
8	lnc-ABCA8-2	chr17:66795023-66795072	XLOC_012558
9	lnc-PRKAR1A-5	chr17:66810067-66810228	FPKM1_group_13223_transcript_1
10	lnc-ABCA8-2	chr17:66793602-66793963	ENSG00000267250.1
11	lnc-ABCA8-2	chr17:66793605-66794254	XLOC_012558

Variant related genes	Relation type
ENSG00000267250	TF binding region
RHEB	miRNA target sites

Extended variants
information (count: 1281 )
Associated
traits (count: 101 )

Variant overlapped rSNPs/rCNVs (count:1281 , 50 per page) page: 1 2 3 4 5 6 7 ... 26

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs8081909	chr17:66787428-66787429	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs8074847	chr17:66787448-66787449	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
3	rs149286395	chr17:66787475-66787476	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs575936619	chr17:66787517-66787518	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs8074899	chr17:66787534-66787535	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs558526205	chr17:66787554-66787555	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs544654198	chr17:66787564-66787565	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs573148188	chr17:66787633-66787634	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs68139244	chr17:66787668-66787669	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs8068546	chr17:66787698-66787699	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs529355164	chr17:66787751-66787752	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs544330002	chr17:66787839-66787840	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs148437052	chr17:66787858-66787859	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs190474594	chr17:66787871-66787872	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs556125254	chr17:66787872-66787873	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs530660485	chr17:66787908-66787909	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs114283501	chr17:66787909-66787910	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs57913837	chr17:66787913-66787914	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs55734961	chr17:66787920-66787921	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs546293441	chr17:66787931-66787932	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs76781621	chr17:66787946-66787947	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs142442700	chr17:66787968-66787969	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs370154067	chr17:66787969-66787970	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs145945118	chr17:66787975-66787976	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs139799885	chr17:66787976-66787977	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs540044705	chr17:66788002-66788003	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs558445125	chr17:66788011-66788012	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs573476050	chr17:66788023-66788024	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs542282198	chr17:66788024-66788025	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs540958097	chr17:66788058-66788059	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs555455953	chr17:66788094-66788095	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs574027754	chr17:66788136-66788137	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs560918760	chr17:66788147-66788148	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs544291187	chr17:66788203-66788204	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs562653683	chr17:66788216-66788217	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs143904340	chr17:66788232-66788233	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs545615298	chr17:66788241-66788242	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs564371226	chr17:66788300-66788301	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs74805810	chr17:66788306-66788307	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs371533875	chr17:66788326-66788327	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs546899799	chr17:66788382-66788383	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs151315788	chr17:66788383-66788384	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs528935188	chr17:66788387-66788388	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs550652503	chr17:66788388-66788389	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs181922076	chr17:66788431-66788432	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs8078115	chr17:66788447-66788448	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs185761254	chr17:66788450-66788451	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs571313846	chr17:66788452-66788453	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs533572925	chr17:66788495-66788496	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs190415415	chr17:66788508-66788509	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:101)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Melanoma	18172304	CNVD
Moyamoya disease	22323933	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Ovarian cancer	21781307	CNVD
Colorectal cancer	21645411	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Medulloblastoma	21979893	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
Chordoma	21602918	CNVD
Neurofibromatosis	20686819	CNVD
Peripheral nerve sheath tumors	20686819	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Cancer	21499728	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	17897457	CNVD
Neuroblastoma	17327916	CNVD
Breast cancer	21264507	CNVD
Endometrial cancer	22040021	CNVD
Neuroblastoma	21484798	CNVD
Breast cancer	22028636	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute myeloid leukemia	20724749	CNVD
lymphocytic leukemia	21291569	CNVD
Gastric cancer	17167181	CNVD
Breast cancer	19287154	CNVD
Leukemia	20874852	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Neuroblastoma	18664255	CNVD
Neuroblastoma	17533364	CNVD
Human rectal carcinomas	16397240	CNVD
Metanephric adenoma	20802469	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Thyroid cancer	19087340	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Neuroblastoma	18923191	CNVD
Bladder cancer	21909424	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Ewing''s sarcoma	18628472	CNVD
Glioblastoma multiforme	18628472	CNVD
Leukemia	18628472	CNVD
Ewing''s sarcoma	22429812	CNVD
Prostate cancer	18632612	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Breast cancer	21509527	CNVD
Chordoma	18071362	CNVD
Cancer	16751803	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	21523713	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21785460	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
Breast cancer	21364760	CNVD
Breast cancer	16397240	CNVD
Breast cancer	17603634	CNVD
Urothelial carcinoma	18382360	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	16608533	CNVD
Breast cancer	21858162	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Congenital Hypertrichosis Syndrome	21636067	CNVD
Cancer	21129771	CNVD
Congenital generalized hypertrichosis terminalis	19463983	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
XY gonadal dysgenesis	20685758	CNVD
Gingival hyperplasia	19463983	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Neuroblastoma	20406844	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16417655	CNVD
Breast cancer	21045282	CNVD
Epilepsy	22083797	CNVD
Sezary syndrome	18413736	CNVD
Honadal dysgenesis	21408189	CNVD
early-passage human iPS cells	21368824	CNVD

Chromatin state (count:430 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:66768600-66789200	Weak transcription	Rectal Smooth Muscle	rectum
2	chr17:66780400-66787600	Weak transcription	Right Atrium	heart
3	chr17:66784800-66789800	Enhancers	HepG2	liver
4	chr17:66785000-66790600	Enhancers	Liver	Liver
5	chr17:66786000-66787800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
6	chr17:66786400-66788000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
7	chr17:66786400-66788200	Enhancers	Fetal Muscle Leg	muscle
8	chr17:66786400-66791000	Enhancers	Adipose Nuclei	Adipose
9	chr17:66786400-66791000	Enhancers	NHDF-Ad	bronchial
10	chr17:66786400-66791200	Enhancers	Muscle Satellite Cultured Cells	--
11	chr17:66786400-66791800	Enhancers	Fetal Lung	lung
12	chr17:66786400-66791800	Enhancers	NHLF	lung
13	chr17:66786600-66788400	Enhancers	Ovary	ovary
14	chr17:66786600-66791200	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
15	chr17:66786800-66787800	Weak transcription	Spleen	Spleen
16	chr17:66786800-66788000	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
17	chr17:66786800-66791000	Enhancers	Osteobl	bone
18	chr17:66787000-66788000	Enhancers	Duodenum Smooth Muscle	Duodenum
19	chr17:66787000-66788200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
20	chr17:66787000-66788200	Enhancers	Primary B cells from peripheral blood	blood
21	chr17:66787000-66791400	Weak transcription	Skeletal Muscle Female	skeletal muscle
22	chr17:66787000-66791800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
23	chr17:66787200-66787800	Weak transcription	Fetal Stomach	stomach
24	chr17:66787200-66788800	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
25	chr17:66787200-66789200	Weak transcription	Fetal Muscle Trunk	muscle
26	chr17:66787200-66789200	Weak transcription	Stomach Smooth Muscle	stomach
27	chr17:66787200-66789800	Weak transcription	Stomach Mucosa	stomach
28	chr17:66787200-66791800	Enhancers	Primary monocytes fromperipheralblood	blood
29	chr17:66787400-66787800	Weak transcription	HSMMtube	muscle
30	chr17:66787400-66788200	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
31	chr17:66787600-66788000	Enhancers	Right Atrium	heart
32	chr17:66787800-66788000	Weak transcription	Fetal Intestine Large	intestine
33	chr17:66787800-66788200	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
34	chr17:66787800-66788200	Enhancers	Skeletal Muscle Male	skeletal muscle
35	chr17:66787800-66788200	Enhancers	Spleen	Spleen
36	chr17:66787800-66789400	Enhancers	HSMMtube	muscle
37	chr17:66787800-66791600	Enhancers	Fetal Stomach	stomach
38	chr17:66788000-66788200	Enhancers	Fetal Intestine Large	intestine
39	chr17:66788000-66788200	Enhancers	Placenta	Placenta
40	chr17:66788000-66788200	Enhancers	Rectal Mucosa Donor 31	rectum
41	chr17:66788000-66789000	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
42	chr17:66788000-66789000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
43	chr17:66788000-66789000	Weak transcription	Duodenum Smooth Muscle	Duodenum
44	chr17:66788000-66789200	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
45	chr17:66788000-66790600	Enhancers	Monocytes-CD14+_RO01746	blood
46	chr17:66788000-66790800	Enhancers	Brain Anterior Caudate	brain
47	chr17:66788000-66791000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
48	chr17:66788000-66791200	Enhancers	Brain Hippocampus Middle	brain
49	chr17:66788000-66791200	Enhancers	Brain Substantia Nigra	brain
50	chr17:66788000-66791200	Enhancers	Hela-S3	cervix

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links